Skip to main content
. 2016 Jun 10;9:302. doi: 10.1186/s13104-016-2101-8

Fig. 2.

Fig. 2

Prevalence of pre-treatment drug resistance mutations among the participants initiating ART and enrolled in the 2008–2010 HIV drug resistance survey